newsfilter
← Latest News
GlobeNewswire·

Landos Biopharma to Present at the 2023 Jefferies Healthcare Conference

NEW YORK, May 31, 2023 (GLOBE NEWSWIRE) -- Landos Biopharma, Inc. (NASDAQ:LABP), a clinical-stage biopharmaceutical company developing novel, oral medicines for patients with autoimmune diseases, today announced that